Danone is launching Oikos Fusion, a dairy-based drink targeting U.S. consumers using weight loss medications like Wegovy.

Discover how GLP-1 medications and the MAHA movement are driving protein consumption and creating new opportunities for ...

Danone is said Oikos Fusion, which is launching in the US, was created “specifically with GLP-1 and weight loss consumers in mind.” ...

The rapid adoption of GLP-1 receptor agonists has fundamentally altered obesity management, with these medications now ...

Researchers suggest all diabetes patients on weight-loss drugs should be regularly screened and monitored for potential eye ...

Leaders at Eli Lilly believe heavy investment in the company's manufacturing footprint “sets a high standard that newcomers ...

SALT LAKE CITY — It was a first-of-its-kind study conducted at the University of Utah on a drug that has, to date, changed ...

In a phase 3 trial, the daily GLP-1 pill has shown "meaningful weight loss" and similar side effects to injectable GLP-1 ...

Scholar Rock Holding Corporation (NASDAQ:SRRK) is among the 11 Best GLP-1 and Weight Loss Stocks to Invest in.

Novo Nordisk A/S (NYSE:NVO) is among the. Novo Nordisk A/S (NYSE:NVO) lowered its operating profit growth projections to ...

Many people around the world are turning to new prescription drugs to help them lose weight. These medicines can work very well while you are taking them, but a new study suggests that the weight loss ...

A warning about weight loss drugs and potential eye damage. Using GLP-1 medications is associated with an increased risk for ...